Overview

A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The overall objective of the study is to assess the effectiveness of switching from immediate-release prednisone (conventional) therapy to delayed-release prednisone (RAYOS) in patients with moderately to severely active Rheumatoid Arthritis (RA), managed according to standard of care in clinical practice settings.
Details
Lead Sponsor:
Horizon Pharma Ireland, Ltd., Dublin Ireland
Treatments:
Prednisone